ArticleFrontiers in oncology2021

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

Yunhai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.